Roche LumiraDx INR test

• Precise results with lab-quality accuracy
• For rapid INR measurements in 60–90 seconds using the LumiraDx point-of-care diagnostic system
• For monitoring oral anticoagulant therapy with vitamin K antagonists (VKA)
• Low sample volume – only 8 µl of blood required
• Quantitative results directly from fresh capillary blood

The LumiraDx INR test is used for the quantitative determination of prothrombin time (INR value) from fresh capillary whole blood. This in vitro diagnostic test is intended for patients aged 18 years and older and supports healthcare professionals in monitoring patients undergoing oral anticoagulant therapy with vitamin K antagonists. As a point-of-care test, it delivers accurate results from a fingerstick sample within 60–90 seconds. Multiple integrated quality controls ensure reliable and correct performance.

Product details

• Suitable for patients aged 18 and over
• Parameter: INR (International Normalized Ratio)
• Detection: quantitative
• Test method: thrombin activity test (fluorescence measurement)
• Sample material: fresh capillary whole blood (direct application or via capillary tube without anticoagulant)
• Measurement time: 60–90 seconds
• Accurate results for supratherapeutic INR values (>4.0) within 90–180 seconds
• Medical specialties: general medicine, internal medicine, laboratory medicine
• Country of origin: UK

Technical specifications

• ISI: approx. 1
• Sample volume: 8 µl
• Measuring range: 0.8–8 INR
• Storage temperature: 5–32 °C
• Operating temperature: 15–30 °C

Package contents

• 48 Roche LumiraDx INR tests